AxoGen, Inc.·4

Jan 22, 9:07 PM ET

Sandberg Eric 4

4 · AxoGen, Inc. · Filed Jan 22, 2019

Insider Transaction Report

Form 4
Period: 2019-01-21
Sandberg Eric
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to purchase)

    2019-01-21+45,00045,000 total
    Exercise: $16.17Exp: 2029-01-21Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on January 21, 2023 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on January 21, 2021 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -